CRP and isolated hyperferritinemia: However, it may be assumed that the mortality risk is much higher in patients who exhibit hyperinflammatory-associated clinical manifestations and biological modifications (for example, elevated levels of C reactive protein, increased levels of D-dimers, hyperferritinemia), these being most probably associated with a high risk of evolution towards MODS.